X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Energy boosts Indian stock markets 
(Wed, 13 Jul 01:30 pm) 
 
Indian stock markets gained further ground during the previous two hours of trade. All sectoral indices are trading firm except Information Technology (IT) index. Stocks from the consumer durables, oil & gas, and auto are the biggest gainers.

The BSE-Sensex is trading up by 145 points while NSE-Nifty is trading 47 points above the dotted line. The BSE Midcap and BSE Small cap indices are up by 1.0% and 0.9% each. The rupee is trading at 44.55 to the US dollar.

Most of the pharma stocks are currently trading firm with Dr Reddy's Laboratories, Glenmark Pharma and Elder Pharma leading the pack of gainers. However, IPCA Labs and Cipla are trading weak. As per a leading financial daily, Dr Reddy's Laboratories (DRL) has received final approval from US Food and Drugs Administration (FDA) to sell Fondaparinux Sodium injection. The latter is used for the treatment and prevention of deep vein thrombosis (DVT). As per the management, it is a complex generic molecule and difficult to manufacture at a large scale. Hence, the company foresees a limited competition for the drug in the near future. It plans to leverage this opportunity. It plans to execute a phased launch in select wholesale and retail outlets, and subsequently enhance share over time in the coming quarters. DRL will manufacture the injection under license using a patented process developed by Australia's Alchemia. Dr Reddy's Fondaparinux Sodium injection is a generic version of GlaxoSmithKline's Arixtra. Arixtra sales grew 16% year-on-year to US$ 340 m for the 12 months ending May 2011.

Realty stocks are trading mixed led by Lok Housing and Constructions, Sobha Developers and Ansal Properties and Infrastructure. However, Godrej Properties, IVRCL Assets and Holdings and Unitech are trading weak. As per a leading financial daily, the Shiv Nadar-controlled HCL Group plans to acquire a substantial stake in DLF Pramerica Life Insurance Company Limited. The deal with real estate major DLF on this acquisition is in the advance stages of discussion. The deal size is estimated to be around Rs 4.5 bn. This acquisition would be the first non-IT diversification for the group.

At present, DLF holds 74% stake in the joint venture with Prudential Financial, the second-largest life insurer in the US. Therefore, the deal may face regulatory hurdle. As per the current guidelines, the original partner in a life insurance joint venture cannot sell its stake in the company during the first ten years of operations. The stock of DLF is currently trading firm.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Energy boosts Indian stock markets". Click here!

  
 

S&P BSE SENSEX


May 29, 2017 (Close)

MARKET STATS